Partner with the Leaders Building Medtech

​Scout develops a smart health testing platform designed to deliver lab-grade diagnostics at home. The system includes the Scout Hub, a portable device that reads and analyzes tests, paired with disposable test kits and a mobile app for result tracking. Scout's technology aims to provide accurate results in under 30 minutes, with clinical studies indicating up to 99% sensitivity compared to traditional lab tests. The platform is currently under development, with plans to launch over-the-counter COVID-19 testing and expand into areas such as respiratory, sexual, and chronic disease diagnostics. Visit website.

Solenic Medical is developing a non-invasive medical device that utilizes alternating magnetic fields to eradicate biofilms that form on implants. The company's platform uses external magnetic coils to destroy infective biofilms on the surface of knee and hip replacement implants, as well as plates and rods for trauma related procedures. Solenic's solution is being developed to replace the expensive and risky two-step revision surgery, which is the current standard of care for chronic infections on medical implants. Visit website.

​Biorithm is a medical technology company focused on advancing maternal and fetal care through digital health solutions. The company's flagship product, femom, is a remote monitoring platform that includes a clinical-grade fetal-maternal monitor, patient-reported symptom tracking, and connected point-of-care devices like blood pressure monitors and glucometers. The femom system enables clinicians to remotely assess the health of expectant mothers and their babies, facilitating early detection of complications and personalized care plans. Currently in the clinical investigation phase, femom aims to enhance continuity of care and empower patients and providers with data-driven insights. Visit website.

​Aqua Medical has developed a vapor-based, through-the-endoscope ablation technology aimed at treating gastrointestinal diseases and preventing gastrointestinal cancers. The RF Vapor Ablation (RFVA) System utilizes heated water vapor delivered via endoscopic catheters to ablate targeted tissue. The system is designed to be fluoroscopy-free and offers a range of catheters to address various conditions throughout the GI tract. Visit website.

BrainSpace is developing a solution to simplify critical care in neurocritical patients. BrainSpace is committed to improving the way brain pressure is managed in patients recovering from stroke, traumatic brain injury, and neurosurgery. Currently patients requiring intracranial pressure management must be meticulously monitored and measured hourly by a nurse. The company has developed an automated monitoring solution as an alternative to the antiquated drainage monitoring relying on a manometer-based drain and blood pressure monitor that eliminates the hassle for patients and providers while improving the quality of data being captured for researchers and physicians. Visit website.

LEM Surgical is focused on creating and providing the next generation of robotic surgical systems. The company's flagship product, the Dynamis System, is a multi-arm robotic surgical system that incorporates novel navigation capabilities and has an open architecture for handling concentric tools. Dynamis is intended to be a platform technology for orthopedic and neurosurgical applications. Visit website.

Efemoral Medical is a clinical stage startup developing a next-generation drug-eluting bioresorbable scaffold for the treatment of PAD. Using a minimally invasive procedure, the Efemoral Vascular Scaffold System is inserted into the leg and expanded inside the artery to restore a channel for blood flow to the foot. The scaffold is strong enough to hold the vessel open, is flexible enough to accommodate the complex skeletal motion of the leg, and elutes a drug to prevent scarring inside the vessel which leads to the need for repeat procedures. The scaffold is naturally absorbed by the body over time, thus leaving behind no permanent implant. Visit website.

​Tensor Surgical develops the TransOs Tunneler System, an anchorless approach to rotator cuff repair and biceps tenodesis. This technique utilizes transosseous suturing to restore the native tendon-bone interface, aiming to enhance biological healing and reduce complications associated with suture anchors. The system is designed to simplify surgical workflows, reduce postoperative pain, and lower procedural costs. Tensor Surgical offers comprehensive training programs to support the adoption of this technique among orthopedic surgeons.​  Visit website.

Hy2Care's vision is to support patients in the fight against osteoarthritis. The company's lead product, CartRevive, is a hydrogel implant composed of dextran and hyaluronic acid conjugates that form a resorbable scaffold when injected. The hydrogel enables natural restoration of tissue defects by creating an environment conducive to cell regrowth that proceeds towards the restoration of smooth hyaline cartilage.  Visit website.

The annual cost of avoidable complications to the entire U.S. healthcare system is $45 billion. KelaHealth has developed a software-as-a-service (SaaS) solution designed to address this problem by accurately predicting who will develop surgical complications and connecting the patient's risks with evidence-based interventions, helping surgeons to adopt actions that prevent complications after surgery. The company's platform uses applied artificial intelligence and big data analytics, to accurately predict and build a personalized report for each patient, for each procedure. Visit website.

NousQ is a Singapore-based company focused on developing patient-centric medical technologies. Its primary product, CLiKX, is a robotic, fully automated, and sensor-optimized handheld applicator designed for ventilation ear tube surgery. CLiKX aims to simplify the procedure by reducing the need for general anesthesia and the surgical microscope, allowing surgeries to be performed in outpatient settings. The device is designed to enhance precision and safety, potentially reducing costs and improving access to care for patients with otitis media effusion. Visit website.

Nevent develops tools to improve safety in vascular access procedures. Its primary product, the NEVENT Safety Sheath, is a patented device designed to prevent the unintended retention of guidewires during catheter-based interventions. Developed by an anesthesiologist, the sheath incorporates a capture mechanism that aims to reduce the risk of complications associated with retained guidewires. Nevent's mission is to engineer out human error in vascular access, thereby improving patient outcomes and operational efficiency in healthcare settings. Visit website.

InkSpace Imaging pioneers a transformative printed electronics platform, initially prioritizing advanced MRI receive coils. These lightweight and flexible coils not only elevate diagnostic imaging, revealing the once invisible, but also expedite scans, enhance patient experiences, reduce the need for sedation, and minimize procedures. Compatible with existing MRI systems and healthcare reimbursement structures, the company's FDA-cleared innovation represents a next-generation approach to accessible, high-quality diagnostics. Visit website.